Showing results (61-70 of 443) with videos related to
Sort By:
Pageof 45
Blood|September 18, 2007
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiencesMohamed L Sorror, Sergio Giralt, Brenda M Sandmaier, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantationRon Ram, Barry Storer, Marco Mielcarek, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigensScott S Tykodi, Edus H Warren, John A Thompson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2025
Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell TransplantationMasumi Ueda Oshima, Phuong T Vo, Michael Boeckh, et al.Leukemia|April 20, 2022
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationLucas C Zarling, Megan Othus, Brenda M Sandmaier, et al.British Journal of Haematology|May 29, 2010
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomasAndrei R Shustov, Theodore A Gooley, Brenda M Sandmaier, et al.Experimental Hematology|October 11, 2003
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcomeWolfgang A Bethge, Barry E Storer, Michael B Maris, et al.British Journal of Haematology|July 22, 2015
Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host diseaseJennifer E Vaughn, Ted Gooley, Richard T Maziarz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2013
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell doseMerav Bar, Brenda M Sandmaier, Yoshihiro Inamoto, et al.Blood|September 13, 2003
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patientsWilliam J Hogan, Michael Maris, Barry Storer, et al.Pageof 45